Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiyun Lin

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Nature|May 13, 2026
Ecotypes of triple-negative breast cancer in response to chemotherapyYun Yan, Yiyun Lin, Tapsi Kumar, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinomaMohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
European Urology Oncology|October 13, 2023
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary TractOmar Alhalabi, Nathaniel Wilson, Lianchun Xiao, et al.
European Urology Oncology|November 18, 2021
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial CancerOmar Alhalabi, Yueting Zhu, Ameer Hamza, et al.
Nature Communications|September 22, 2020
Telomere dysfunction activates YAP1 to drive tissue inflammationDeepavali Chakravarti, Baoli Hu, Xizeng Mao, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Nature|May 13, 2026
Ecotypes of triple-negative breast cancer in response to chemotherapyYun Yan, Yiyun Lin, Tapsi Kumar, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinomaMohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
European Urology Oncology|October 13, 2023
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary TractOmar Alhalabi, Nathaniel Wilson, Lianchun Xiao, et al.
European Urology Oncology|November 18, 2021
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial CancerOmar Alhalabi, Yueting Zhu, Ameer Hamza, et al.
Nature Communications|September 22, 2020
Telomere dysfunction activates YAP1 to drive tissue inflammationDeepavali Chakravarti, Baoli Hu, Xizeng Mao, et al.
Pageof 5